Empegfilgrastim
Empegfilgrastim Uses, Dosage, Side Effects, Food Interaction and all others data.
Empegfilgrastim is under investigation in clinical trial NCT01569087 (Dose-finding Study of Empegfilgrastim for Neutropenia Prophylaxis in Patients With Breast Cancer).
| Trade Name | Empegfilgrastim |
| Generic | Empegfilgrastim |
| Empegfilgrastim Other Names | Colony-stimulating factor, granulocyte (synthetic human), 30-kilodalton pegylated, Empegfilgrastim |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Empegfilgrastim
